Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice (JOPP) is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer AD describing innovative pharmacy distributive and clinical models.
Please note: JOPP does not include any preclinical studies and authors should consider submitting these types of papers to the appropriate Sage journal.
As the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP), the Journal of Oncology Pharmacy Practice contains regular updates on ISOPP activities, as well as practical issues relating to oncology pharmacy and worker safety.
This journal is a member of the Committee on Publication Ethics (COPE).
Journal of Oncology Pharmacy Practice is a peer-reviewed scholarly journal dedicated to educating health professionals about providing pharmaceutical care to patients with cancer and is the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP).
As the official publication of the International Society for Oncology Pharmacy Practitioners (ISOPP), the Journal of Oncology Pharmacy Practice contains regular updates on ISOPP activities, as well as practical issues relating to oncology pharmacy and worker safety.
JOPP articles include:
-
Comprehensive and critical reviews of drug use in cancer patient care
-
Information on new products, new therapies and patient management
-
Research related to oncology pharmacy practice
-
Institutional policies on medication use
-
Reports of innovative services, policies, and outcome measure tools
-
Brief comments on articles published in the journal or other information of interest
-
Opinions about controversial therapeutic areas and comments about practice-related issues
Please note: JOPP does not include:
-
Preclinical studies except medication stability/compatibility
-
Research on efficacy of cancer treatments
-
Papers solely reporting radiation or surgery for cancer management
Authors should contact the editor (brgoldspiel@gmail.com) if they have a question about whether a proposed paper falls within the scope of the Journal of Oncology Pharmacy Practice before submitting their manuscript.
Barry R Goldspiel | Bethesda, MD, USA |
Alexandre Chan | University of California, Irvine, CA, USA |
Graham Sewell (Emeritis) | Plymouth University, UK |
Marliese Alexander | Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Australia |
M. Brooke Bernhardt | Baylor College of Medicine, Houston, Texas, USA |
John E Brown | Kingston University, UK |
Carole Chambers | Alberta Health Services Pharmacy, Canada |
Thomas Connor | Cincinnati, USA |
Sylvie Crauste-Manciet | University of Paris V - Rene Descartes, France |
Melanie Dalby | King’s College Hospital NHS Foundation Trust, London UK |
Mario De Lemos | BC Cancer Agency, Vancouver, Canada |
George Dranitsaris | Ontario Cancer Institute (OCI), Princess Margaret Hospital, Ontario, Canada |
Salim Hadad | Rambam Health Care Campus, Haifa, Israel |
Lisa Holle | University of Connecticut School of Pharmacy, Storrs, CT, USA |
Sabine Kaestner | University Hospital Malmo, Sweden |
Esin Aysel Kandemir | Carl von Ossietzky University of Oldenburg, Wiefelstede Germany |
Polly E Kintzel | Spectrum Health Hospitals, USA |
Shereen Nabhani | Kingston University, UK |
Lynne Nakashima | BC Cancer Agency, Vancouver Cancer Centre, Canada |
Manit Saeteaw | Ubon Ratchathani University, Ubon Ratchathani, Thailand |
Rowena Schwartz | University of Cincinnati, USA |
Judith Smith | The University of Texas Health Science Center at Houston, USA |
Lindsay Stansfield | Denver Health, Denver, CO, USA |
Nicola Stoner | Cancer Research UK, Oxford, UK |
Gunter Wiedemann | Oberschwabenklinik, Ravensburg, Germany |
Keary Zhou | The Chinese University of Hong Kong, Shatin, N.T., Hong Kong |
Manuscript submission guidelines can be accessed on Sage Journals.